vs
CORCEPT THERAPEUTICS INC（CORT）与CSW INDUSTRIALS, INC.（CSW）财务数据对比。点击上方公司名可切换其他公司
CSW INDUSTRIALS, INC.的季度营收约是CORCEPT THERAPEUTICS INC的1.2倍（$233.0M vs $202.1M），CORCEPT THERAPEUTICS INC净利率更高（12.0% vs 4.4%，领先7.6%），CSW INDUSTRIALS, INC.同比增速更快（20.3% vs 11.1%），CORCEPT THERAPEUTICS INC自由现金流更多（$38.4M vs $22.7M），过去两年CORCEPT THERAPEUTICS INC的营收复合增速更高（17.3% vs 5.1%）
Corcept Therapeutics是一家制药企业，专注于严重代谢疾病、精神疾病及肿瘤疾病治疗药物的发现、开发与商业化。公司围绕皮质醇过量带来的不良影响展开研究，致力于开发可缓解相关症状的新型化合物，管理团队由首席执行官兼总裁、董事Joseph K. Belanoff医学博士领导。
CORT vs CSW — 直观对比
营收规模更大
CSW
是对方的1.2倍
$202.1M
营收增速更快
CSW
高出9.2%
11.1%
净利率更高
CORT
高出7.6%
4.4%
自由现金流更多
CORT
多$15.7M
$22.7M
两年增速更快
CORT
近两年复合增速
5.1%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $202.1M | $233.0M |
| 净利润 | $24.3M | $10.3M |
| 毛利率 | 98.7% | 39.7% |
| 营业利润率 | 2.2% | 7.4% |
| 净利率 | 12.0% | 4.4% |
| 营收同比 | 11.1% | 20.3% |
| 净利润同比 | -21.0% | -61.9% |
| 每股收益（稀释后） | $0.20 | $0.62 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CORTCSW
| Q4 25 | $202.1M | $233.0M | ||
| Q3 25 | $207.6M | $277.0M | ||
| Q2 25 | $194.4M | $263.6M | ||
| Q1 25 | $157.2M | $230.5M | ||
| Q4 24 | $181.9M | $193.6M | ||
| Q3 24 | $182.5M | $227.9M | ||
| Q2 24 | $163.8M | $226.2M | ||
| Q1 24 | $146.8M | $210.9M |
净利润CORTCSW
| Q4 25 | $24.3M | $10.3M | ||
| Q3 25 | $19.7M | $40.7M | ||
| Q2 25 | $35.1M | $40.9M | ||
| Q1 25 | $20.5M | $35.1M | ||
| Q4 24 | $30.7M | $26.9M | ||
| Q3 24 | $47.2M | $36.1M | ||
| Q2 24 | $35.5M | $38.6M | ||
| Q1 24 | $27.8M | $31.8M |
毛利率CORTCSW
| Q4 25 | 98.7% | 39.7% | ||
| Q3 25 | 97.8% | 43.0% | ||
| Q2 25 | 98.2% | 43.8% | ||
| Q1 25 | 98.5% | 44.2% | ||
| Q4 24 | 98.4% | 41.4% | ||
| Q3 24 | 98.4% | 45.6% | ||
| Q2 24 | 98.5% | 47.5% | ||
| Q1 24 | 98.3% | 44.4% |
营业利润率CORTCSW
| Q4 25 | 2.2% | 7.4% | ||
| Q3 25 | 4.9% | 20.5% | ||
| Q2 25 | 13.7% | 20.8% | ||
| Q1 25 | 2.2% | 19.5% | ||
| Q4 24 | 13.9% | 15.3% | ||
| Q3 24 | 25.5% | 22.6% | ||
| Q2 24 | 21.7% | 24.3% | ||
| Q1 24 | 20.1% | 21.0% |
净利率CORTCSW
| Q4 25 | 12.0% | 4.4% | ||
| Q3 25 | 9.5% | 14.7% | ||
| Q2 25 | 18.1% | 15.5% | ||
| Q1 25 | 13.1% | 15.2% | ||
| Q4 24 | 16.9% | 13.9% | ||
| Q3 24 | 25.9% | 15.8% | ||
| Q2 24 | 21.7% | 17.1% | ||
| Q1 24 | 18.9% | 15.1% |
每股收益（稀释后）CORTCSW
| Q4 25 | $0.20 | $0.62 | ||
| Q3 25 | $0.16 | $2.41 | ||
| Q2 25 | $0.29 | $2.43 | ||
| Q1 25 | $0.17 | $2.05 | ||
| Q4 24 | $0.25 | $1.60 | ||
| Q3 24 | $0.41 | $2.26 | ||
| Q2 24 | $0.32 | $2.47 | ||
| Q1 24 | $0.25 | $2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $372.2M | $40.2M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $647.8M | $1.1B |
| 总资产 | $836.7M | $2.3B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CORTCSW
| Q4 25 | $372.2M | $40.2M | ||
| Q3 25 | $421.7M | $31.5M | ||
| Q2 25 | $342.2M | $38.0M | ||
| Q1 25 | $322.8M | $225.8M | ||
| Q4 24 | $383.3M | $213.8M | ||
| Q3 24 | $380.3M | $273.2M | ||
| Q2 24 | $473.2M | $18.9M | ||
| Q1 24 | $410.8M | $22.2M |
总债务CORTCSW
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $800.1M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $166.0M |
股东权益CORTCSW
| Q4 25 | $647.8M | $1.1B | ||
| Q3 25 | $631.9M | $1.1B | ||
| Q2 25 | $635.8M | $1.1B | ||
| Q1 25 | $683.3M | $1.1B | ||
| Q4 24 | $679.6M | $1.0B | ||
| Q3 24 | $638.8M | $1.0B | ||
| Q2 24 | $596.2M | $650.2M | ||
| Q1 24 | $547.9M | $615.7M |
总资产CORTCSW
| Q4 25 | $836.7M | $2.3B | ||
| Q3 25 | $823.6M | $1.5B | ||
| Q2 25 | $801.7M | $1.5B | ||
| Q1 25 | $846.5M | $1.4B | ||
| Q4 24 | $840.6M | $1.4B | ||
| Q3 24 | $784.3M | $1.4B | ||
| Q2 24 | $714.6M | $1.1B | ||
| Q1 24 | $655.9M | $1.0B |
负债/权益比CORTCSW
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 0.75× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.27× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $38.4M | $28.9M |
| 自由现金流经营现金流 - 资本支出 | $38.4M | $22.7M |
| 自由现金流率自由现金流/营收 | 19.0% | 9.8% |
| 资本支出强度资本支出/营收 | 0.0% | 2.6% |
| 现金转化率经营现金流/净利润 | 1.58× | 2.81× |
| 过去12个月自由现金流最近4个季度 | — | $162.0M |
8季度趋势，按日历期对齐
经营现金流CORTCSW
| Q4 25 | $38.4M | $28.9M | ||
| Q3 25 | $54.5M | $61.8M | ||
| Q2 25 | $43.9M | $60.6M | ||
| Q1 25 | $5.1M | $27.3M | ||
| Q4 24 | $59.3M | $11.6M | ||
| Q3 24 | $73.8M | $66.8M | ||
| Q2 24 | $41.2M | $62.7M | ||
| Q1 24 | $23.8M | $22.4M |
自由现金流CORTCSW
| Q4 25 | $38.4M | $22.7M | ||
| Q3 25 | — | $58.7M | ||
| Q2 25 | $43.9M | $57.7M | ||
| Q1 25 | $5.0M | $22.8M | ||
| Q4 24 | $59.2M | $8.5M | ||
| Q3 24 | $72.2M | $61.3M | ||
| Q2 24 | $40.8M | $59.6M | ||
| Q1 24 | — | $17.5M |
自由现金流率CORTCSW
| Q4 25 | 19.0% | 9.8% | ||
| Q3 25 | — | 21.2% | ||
| Q2 25 | 22.6% | 21.9% | ||
| Q1 25 | 3.2% | 9.9% | ||
| Q4 24 | 32.5% | 4.4% | ||
| Q3 24 | 39.5% | 26.9% | ||
| Q2 24 | 24.9% | 26.3% | ||
| Q1 24 | — | 8.3% |
资本支出强度CORTCSW
| Q4 25 | 0.0% | 2.6% | ||
| Q3 25 | 0.0% | 1.1% | ||
| Q2 25 | 0.0% | 1.1% | ||
| Q1 25 | 0.1% | 2.0% | ||
| Q4 24 | 0.1% | 1.6% | ||
| Q3 24 | 0.9% | 2.4% | ||
| Q2 24 | 0.3% | 1.4% | ||
| Q1 24 | 0.0% | 2.3% |
现金转化率CORTCSW
| Q4 25 | 1.58× | 2.81× | ||
| Q3 25 | 2.77× | 1.52× | ||
| Q2 25 | 1.25× | 1.48× | ||
| Q1 25 | 0.25× | 0.78× | ||
| Q4 24 | 1.93× | 0.43× | ||
| Q3 24 | 1.56× | 1.85× | ||
| Q2 24 | 1.16× | 1.62× | ||
| Q1 24 | 0.86× | 0.71× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CORT
暂无分部数据
CSW
| Contractor Solutions Segment | $166.3M | 71% |
| Specialized Reliability Solutions Segment | $38.2M | 16% |
| Engineered Building Solutions Segment | $28.5M | 12% |
